These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8398989)

  • 1. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice.
    Köntgen F; Süss G; Stewart C; Steinmetz M; Bluethmann H
    Int Immunol; 1993 Aug; 5(8):957-64. PubMed ID: 8398989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive CD8 expression allows inefficient maturation of CD4+ helper T cells in class II major histocompatibility complex mutant mice.
    Robey E; Itano A; Fanslow WC; Fowlkes BJ
    J Exp Med; 1994 Jun; 179(6):1997-2004. PubMed ID: 7515104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.
    Crompton T; Lees RK; Pircher H; MacDonald HR
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8982-6. PubMed ID: 8415641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of T cell receptor expression in immature CD4+CD8+ thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules.
    Wiest DL; Yuan L; Jefferson J; Benveniste P; Tsokos M; Klausner RD; Glimcher LH; Samelson LE; Singer A
    J Exp Med; 1993 Nov; 178(5):1701-12. PubMed ID: 8228817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The final maturation of at least some single-positive CD4(hi) thymocytes does not require T cell receptor-major histocompatibility complex contact.
    Dyall R; Nikolic-Zugić J
    J Exp Med; 1999 Sep; 190(6):757-64. PubMed ID: 10499914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate steps in positive selection: differentiation of CD4+8int TCRint thymocytes into CD4-8+TCRhi thymocytes.
    Lundberg K; Heath W; Köntgen F; Carbone FR; Shortman K
    J Exp Med; 1995 May; 181(5):1643-51. PubMed ID: 7722444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes.
    Coles MC; Raulet DH
    J Exp Med; 1994 Jul; 180(1):395-9. PubMed ID: 8006596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturational arrest from CD4+8+ to CD4+8- thymocytes in a mutant strain (LEC) of rat.
    Agui T; Oka M; Yamada T; Sakai T; Izumi K; Ishida Y; Himeno K; Matsumoto K
    J Exp Med; 1990 Dec; 172(6):1615-24. PubMed ID: 2147947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice.
    Bochtler P; Wahl C; Schirmbeck R; Reimann J
    J Immunol; 2006 Dec; 177(12):8307-14. PubMed ID: 17142726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities.
    Bogen B; Gleditsch L; Weiss S; Dembic Z
    Eur J Immunol; 1992 Mar; 22(3):703-9. PubMed ID: 1547816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells.
    Killeen N; Moriarty A; Teh HS; Littman DR
    J Exp Med; 1992 Jul; 176(1):89-97. PubMed ID: 1613468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cytokines and glucocorticoids on endogenous class II MHC antigen expression by activated rat CD4+ T cells. Mature CD4+ CD8- thymocytes are phenotypically heterogeneous on activation.
    Seddon B; Mason D
    Int Immunol; 1996 Aug; 8(8):1185-93. PubMed ID: 8918687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant Disruption of
    Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
    J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells.
    Kast WM; de Waal LP; Melief CJ
    J Exp Med; 1984 Dec; 160(6):1752-66. PubMed ID: 6096476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of mature CD8+ thymocytes: selection rather than instruction?
    van Meerwijk JP; Germain RN
    Science; 1993 Aug; 261(5123):911-5. PubMed ID: 8102208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function.
    Yeung RS; Penninger JM; Kündig TM; Law Y; Yamamoto K; Kamikawaji N; Burkly L; Sasazuki T; Flavell R; Ohashi PS; Mak TW
    J Exp Med; 1994 Nov; 180(5):1911-20. PubMed ID: 7964466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.